US EditionPublished • loading... • Updated
Diagens nears IPO with medical imaging AI, foundation model
Summary by KrASIA
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Diagens nears IPO with medical imaging AI, foundation model
Diagens Biotechnology has passed a listing hearing with the Hong Kong Stock Exchange and disclosed its post-hearing prospectus on March 15, with Huatai International serving as the sole sponsor. The move puts the Hangzhou-based firm on track to become the world’s first publicly listed company offering artificial intelligence-driven tools and solutions built on a medical imaging foundation model. Founded in 2016, Diagens develops medical imaging …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
